Tratamiento de piodermias por estafilococos multirresistentes

  1. Ana María Goicoa Valdevira
  2. Juan Rejas López
Revista:
Argos: Informativo Veterinario

ISSN: 1699-7875

Año de publicación: 2020

Título del ejemplar: Dermatología

Número: 217

Páginas: 54-55

Tipo: Artículo

DIALNET GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Argos: Informativo Veterinario

Resumen

En las últimas dos décadas, por el uso excesivo de los antibióticos, han aparecido Staphylococcus pseudintermedius resistentes a muchos de los antibióticos usados habitualmente; estos estafilococos, sin embargo, no suelen mostrar resistencias a los antisépticos. Por ello, la terapia debe evitar el uso de antibióticos en la medida de lo posible.

Referencias bibliográficas

  • AGENCIA ESPAÑOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS. Furacin. Ficha técnica. https://www.aemps.gob.es/cima/pdfs/es/ft/16737/FichaTecnica_16737.html.pdf. Año de publicación: 2007.
  • BANOVIC F, LEMO N. In vitro evaluation of the use of diluted sodium hypochlorite (bleach) against Staphylococcus pseudintermedius, Pseudomonas aeruginosa and Malassezia pachydermatis. Vet Dermatol, 2014; 25(3):233-234. doi:10.1111/vde.12121.
  • BANOVIC F, OLIVRY T, BÄUMER W, et al. Diluted sodium hypochlorite (bleach) in dogs: antiseptic efficacy, local tolerability and in vitro effect on skin barrier function and inflammation. Vet Dermatol, 2018; 29(1):6-e5. doi:10.1111/vde.12487.
  • BECO L, GUAGUÈRE E, LORENTE MÉNDEZ C, et al. Suggested guidelines for using systemic antimicrobials in bacterial skin infections: (2) antimicrobial choice, treatment regimens and compliance. Vet Rec, 2013; 172(6):156-160. doi:10.1136/vr.101070.
  • BLANCO AD, WOLBERG A. Double-blinded comparative study of the efficacy of azithromycin and cephalexin in canine pyoderma. Vet Dermatol, 2004; 15(Suppl. 1):42-42. doi:10.1111/j.1365-3164.2004.00414_6.x.
  • BLOOM P. Canine superficial bacterial folliculitis: current understanding of its etiology, diagnosis and treatment. Vet J, 2014; 199(2):217-222. doi:10.1016/J.TVJL.2013.11.014.
  • BORIO S, COLOMBO S, LA ROSA G, et al. Effectiveness of a combined (4% chlorhexidine digluconate shampoo and solution) protocol in MRS and non-MRS canine superficial pyoderma: a randomized, blinded, antibiotic-controlled study. Vet Dermatol, 2015; 26(5):339-e72. doi:10.1111/vde.12233.
  • BOYEN F, VERSTAPPEN KMHW, DE BOCK M, et al. In vitro antimicrobial activity of miconazole and polymyxin B against canine meticillin-resistant Staphylococcus aureus and meticillin-resistant Staphylococcus pseudintermedius isolates. Vet Dermatol, 2012; 23(4):381-e70. doi:10.1111/j.1365-3164.2012.01040.x.
  • CLARK SM, LOEFFLER A, BOND R. Susceptibility in vitro of canine methicillin-resistant and -susceptible staphylococcal isolates to fusidic acid, chlorhexidine and miconazole: opportunities for topical therapy of canine superficial pyoderma. J Antimicrob Chemother, 2015; 70(7):2048-2052. doi:10.1093/jac/dkv056.
  • COBB MA, EDWARDS HJ, JAGGER TD, et al. Topical fusidic acid/betamethasone-containing gel compared to systemic therapy in the treatment of canine acute moist dermatitis. Vet J, 2005; 169(2):276-280. doi:10.1016/J.TVJL.2004.01.017.
  • CHANCHAITHONG P, PRAPASARAKUL N. Occurrence and characterization of inducible clindamycin resistance in canine methicillin-resistant Staphylococcus pseudintermedius. Vet J, 2016; 208:99-101. doi:10.1016/J.TVJL.2015.08.018.
  • DUIJKEREN E VAN, CATRY B, GREKO C, et al. Review on methicillin-resistant Staphylococcus pseudintermedius. J Antimicrob Chemother, 2011; 66(12):2705-2714. doi:10.1093/jac/dkr367.
  • FRANK LA, LOEFFLER A. Meticillin-resistant Staphylococcus pseudintermedius: clinical challenge and treatment options. Vet Dermatol, 2012; 23(4):283-e56. doi:10.1111/j.1365-3164.2012.01047.x.
  • FROSINI S-M, BOND R, LOEFFLER A, LARNER J. Opportunities for topical antimicrobial therapy: permeation of canine skin by fusidic acid. BMC Vet Res, 2017; 13(1):345. doi:10.1186/s12917-017-1270-6.
  • GOLD RM, LAWHON SD. Incidence of inducible clindamycin resistance in Staphylococcus pseudintermedius from dogs. J Clin Microbiol, 2013; 51(12):4196-4199. doi:10.1128/JCM.02251-13.
  • HILLIER A, LLOYD DH, WEESE JS, et al. Guidelines for the diagnosis and antimicrobial therapy of canine superficial bacterial folliculitis (Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases). Vet Dermatol, 2014; 25(3):163-e43. doi:10.1111/vde.12118.
  • JEFFERS JG. Topical therapy for drug-resistant pyoderma in small animals. Vet Clin North Am Small Anim Pract, 2013; 43(1):41-50. doi:10.1016/j.cvsm.2012.09.006.
  • KOCH SN, TORRES SMF, PLUMB DC. Topical agents. En: Canine and Feline Dermatology Drug Handbook. Ames: Wiley-Blackwell; 2012:219-394.
  • LOEFFLER A, BAINES SJ, TOLEMAN MS, et al. In vitro activity of fusidic acid and mupirocin against coagulase-positive staphylococci from pets. J Antimicrob Chemother, 2008; 62(6):1301-1304. doi:10.1093/jac/dkn398.
  • LUCIA M DE, BARDAGI M, FABBRI E, et al. Rifampicin treatment of canine pyoderma due to multidrug-resistant meticillin-resistant staphylococci: a retrospective study of 32 cases. Vet Dermatol, 2017; 28(2):171-e36. doi:10.1111/vde.12404.
  • LLOYD DH, VARJONEN EK. Resisting the resistance. Is there progress in maintaining antimicrobial efficacy? En: Advances in Veterinary Dermatology. Chichester, UK: John Wiley & Sons, Ltd; 2017:199-205. doi:10.1002/9781119278368.ch7.3.
  • MORRIS DO, LOEFFLER A, DAVIS MF, et al. Recommendations for approaches to meticillin-resistant staphylococcal infections of small animals: diagnosis, therapeutic considerations and preventative measures. Clinical consensus guidelines of the World Association for Veterinary Dermatology. Vet Dermatol, 2017; 28(3):304-e69. doi:10.1111/vde.12444.
  • NOLI C, MORRIS D. Guidelines on the use of systemic aminoglycosides in veterinary dermatology. Vet Dermatol, 2011; 22(4):379-380. doi:10.1111/j.1365-3164.2011.00991.x.
  • OSLAND AM, VESTBY LK, FANUELSEN H, et al. Clonal diversity and biofilm-forming ability of methicillin-resistant Staphylococcus pseudintermedius. J Antimicrob Chemother, 2012; 67(4):841-848. doi:10.1093/jac/dkr576.
  • PAPICH MG. Selection of antibiotics for meticillin-resistant Staphylococcus pseudintermedius: time to revisit some old drugs? Vet Dermatol, 2012; 23(4):352-e64. doi:10.1111/j.1365-3164.2011.01030.x.
  • PARISER M, GARD S, GRAM D, SCHMEITZEL L. An in vitro study to determine the minimal bactericidal concentration of sodium hypochlorite (bleach) required to inhibit meticillin-resistant Staphylococcus pseudintermedius strains isolated from canine skin. Vet Dermatol, 2013; 24(6):632-e157. doi:10.1111/vde.12079.
  • PATERSON S. Rational use of antibiotics in skin disease. Companion Anim, 2017; 22(11):632-639. doi:10.12968/coan.2017.22.11.632.
  • PORRAS-LUQUE JI. Antimicrobianos tópicos en dermatología. Actas Dermosifiliogr, 2007; 98(Suppl. 1):29-39. doi:10.1016/S0001-7310(07)70179-5.
  • URI M, BUCKLEY LM, MARRIAGE L, et al. A pilot study comparing in vitro efficacy of topical preparations against veterinary pathogens. Vet Dermatol, 2016; 27(3):152-e39. doi:10.1111/vde.12306.
  • VALENTINE BK, DEW W, YU A, WEESE JS. In vitro evaluation of topical biocide and antimicrobial susceptibility of Staphylococcus pseudintermedius from dogs. Vet Dermatol, 2012; 23(6):493-e95. doi:10.1111/j.1365-3164.2012.01095.x.
  • ZUR G, SOBACK S, WEISS Y, et al. Azithromycin pharmacokinetics in the serum and its distribution to the skin in healthy dogs and dogs with pyoderma. Vet J, 2014; 200(1):122-126. doi:10.1016/J.TVJL.2013.12.022.
Fuente de los datos: Dialnet